154 Marrow-infiltrating lymphocytes (MILs): A novel adoptive immunotherapy for hematological and solid tumors

Bibliographic Details
Main Authors: David Page, Eric Lutz, Ivan Borrello, Daniela Bota, Paul Swiecicki, Lakshmi Rudraraju, Elizabeth DeOliveira, Amanda Seiz, Monil Shah, Celine Colmenares, Beverly Dan Fu, Collin Brummel, Chad Brenner, Nicole Fredrich, Eleni Efstatihiou, Kimberly Noonan
Format: Article
Language:English
Published: BMJ Publishing Group 2020-11-01
Series:Journal for ImmunoTherapy of Cancer
id doaj-9b9a048090fd4ce8a383c04226983b48
record_format Article
spelling doaj-9b9a048090fd4ce8a383c04226983b482020-12-11T10:05:11ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262020-11-018Suppl 310.1136/jitc-2020-SITC2020.0154154 Marrow-infiltrating lymphocytes (MILs): A novel adoptive immunotherapy for hematological and solid tumorsDavid Page0Eric Lutz1Ivan Borrello2Daniela Bota3Paul Swiecicki4Lakshmi Rudraraju5Elizabeth DeOliveira6Amanda Seiz7Monil Shah8Celine Colmenares9Beverly Dan Fu10Collin Brummel11Chad Brenner12Nicole Fredrich13Eleni Efstatihiou14Kimberly Noonan15Aff319 grid.240531.1000000040456863XEarle A. Chiles Research Institute, Providence Portland Medical Center Portland OR USA Aff1 grid.21107.350000000121719311OncologyJohns Hopkins University Baltimore MD USA Aff11 grid.21107.350000000121719311Johns Hopkins School of Medicine 1650 Orleans St 21231 Baltimore MD USA 1Unviersity of California, Irvine, Orange, USA5University of Michigan, Ann Arbor, MI, USA1WindMIL Therapeutics, Baltimore, MD, USA1WindMIL Therapeutics, Baltimore, MD, USA1WindMIL Therapeutics, Baltimore, MD, USA1WindMIL Therapeutics, Baltimore, MD, USA2University of California – Irvine, Irvine, CA, USA2University of California – Irvine, Irvine, CA, USA3University of Michigan, Ann Arbor, MI, USA3University of Michigan, Ann Arbor, MI, USA4Providence Portland Medical Center, Portland, OR, USA5The University of Texas MD Anderson Canc, Houston, TX, USA1WindMIL Therapeutics, Baltimore, MD, USA
collection DOAJ
language English
format Article
sources DOAJ
author David Page
Eric Lutz
Ivan Borrello
Daniela Bota
Paul Swiecicki
Lakshmi Rudraraju
Elizabeth DeOliveira
Amanda Seiz
Monil Shah
Celine Colmenares
Beverly Dan Fu
Collin Brummel
Chad Brenner
Nicole Fredrich
Eleni Efstatihiou
Kimberly Noonan
spellingShingle David Page
Eric Lutz
Ivan Borrello
Daniela Bota
Paul Swiecicki
Lakshmi Rudraraju
Elizabeth DeOliveira
Amanda Seiz
Monil Shah
Celine Colmenares
Beverly Dan Fu
Collin Brummel
Chad Brenner
Nicole Fredrich
Eleni Efstatihiou
Kimberly Noonan
154 Marrow-infiltrating lymphocytes (MILs): A novel adoptive immunotherapy for hematological and solid tumors
Journal for ImmunoTherapy of Cancer
author_facet David Page
Eric Lutz
Ivan Borrello
Daniela Bota
Paul Swiecicki
Lakshmi Rudraraju
Elizabeth DeOliveira
Amanda Seiz
Monil Shah
Celine Colmenares
Beverly Dan Fu
Collin Brummel
Chad Brenner
Nicole Fredrich
Eleni Efstatihiou
Kimberly Noonan
author_sort David Page
title 154 Marrow-infiltrating lymphocytes (MILs): A novel adoptive immunotherapy for hematological and solid tumors
title_short 154 Marrow-infiltrating lymphocytes (MILs): A novel adoptive immunotherapy for hematological and solid tumors
title_full 154 Marrow-infiltrating lymphocytes (MILs): A novel adoptive immunotherapy for hematological and solid tumors
title_fullStr 154 Marrow-infiltrating lymphocytes (MILs): A novel adoptive immunotherapy for hematological and solid tumors
title_full_unstemmed 154 Marrow-infiltrating lymphocytes (MILs): A novel adoptive immunotherapy for hematological and solid tumors
title_sort 154 marrow-infiltrating lymphocytes (mils): a novel adoptive immunotherapy for hematological and solid tumors
publisher BMJ Publishing Group
series Journal for ImmunoTherapy of Cancer
issn 2051-1426
publishDate 2020-11-01
work_keys_str_mv AT davidpage 154marrowinfiltratinglymphocytesmilsanoveladoptiveimmunotherapyforhematologicalandsolidtumors
AT ericlutz 154marrowinfiltratinglymphocytesmilsanoveladoptiveimmunotherapyforhematologicalandsolidtumors
AT ivanborrello 154marrowinfiltratinglymphocytesmilsanoveladoptiveimmunotherapyforhematologicalandsolidtumors
AT danielabota 154marrowinfiltratinglymphocytesmilsanoveladoptiveimmunotherapyforhematologicalandsolidtumors
AT paulswiecicki 154marrowinfiltratinglymphocytesmilsanoveladoptiveimmunotherapyforhematologicalandsolidtumors
AT lakshmirudraraju 154marrowinfiltratinglymphocytesmilsanoveladoptiveimmunotherapyforhematologicalandsolidtumors
AT elizabethdeoliveira 154marrowinfiltratinglymphocytesmilsanoveladoptiveimmunotherapyforhematologicalandsolidtumors
AT amandaseiz 154marrowinfiltratinglymphocytesmilsanoveladoptiveimmunotherapyforhematologicalandsolidtumors
AT monilshah 154marrowinfiltratinglymphocytesmilsanoveladoptiveimmunotherapyforhematologicalandsolidtumors
AT celinecolmenares 154marrowinfiltratinglymphocytesmilsanoveladoptiveimmunotherapyforhematologicalandsolidtumors
AT beverlydanfu 154marrowinfiltratinglymphocytesmilsanoveladoptiveimmunotherapyforhematologicalandsolidtumors
AT collinbrummel 154marrowinfiltratinglymphocytesmilsanoveladoptiveimmunotherapyforhematologicalandsolidtumors
AT chadbrenner 154marrowinfiltratinglymphocytesmilsanoveladoptiveimmunotherapyforhematologicalandsolidtumors
AT nicolefredrich 154marrowinfiltratinglymphocytesmilsanoveladoptiveimmunotherapyforhematologicalandsolidtumors
AT eleniefstatihiou 154marrowinfiltratinglymphocytesmilsanoveladoptiveimmunotherapyforhematologicalandsolidtumors
AT kimberlynoonan 154marrowinfiltratinglymphocytesmilsanoveladoptiveimmunotherapyforhematologicalandsolidtumors
_version_ 1724386475176361984